These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1648792)

  • 1. Action of modified heparins on coagulation: in vitro and in vivo studies.
    Stemberger AW; Riedl A; Haas S; Breddin HK; Walenga JM; Blümel G
    Semin Thromb Hemost; 1991; 17 Suppl 1():80-4. PubMed ID: 1648792
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical evaluation of a new one-stage clotting assay for heparin and low molecular weight heparins.
    Harenberg J
    J Mal Vasc; 1987; 12 Suppl B():68-70. PubMed ID: 2834495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative neutralization of the biological actions of sulfaminoheparosans (K5 derivatives) and heparins by protamine sulfate.
    Maddineni J; Hoppensteadt DA; Cornelli U; Manoni M; Fareed J
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):52-64. PubMed ID: 17164496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin and low-molecular-weight heparin.
    Gray E; Mulloy B; Barrowcliffe TW
    Thromb Haemost; 2008 May; 99(5):807-18. PubMed ID: 18449410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro anticoagulation monitoring of low-molecular-weight heparin.
    Wang JQ; Shi XB; Yang JG; Hu DY
    Chin Med J (Engl); 2009 May; 122(10):1199-202. PubMed ID: 19493471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low molecular weight heparins: antithrombotic and haemorrhagic effects and standardization.
    Barrowcliffe TW; Thomas DP
    Acta Chir Scand Suppl; 1988; 543():57-64. PubMed ID: 2847459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein lipase, hepatic lipase and plasma lipolytic activity. Effects of heparin and a low molecular weight heparin fragment (Fragmin).
    Persson E
    Acta Med Scand Suppl; 1988; 724():1-56. PubMed ID: 2843005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative analysis of unfractionated and low molecular weight heparins on the polymerization process of fibrin].
    Barkagan ZS; Solomina TA
    Biull Eksp Biol Med; 1997 Sep; 124(9):346-7. PubMed ID: 9445624
    [No Abstract]   [Full Text] [Related]  

  • 9. [Determination of anticoagulant activity of heparin].
    Dalmora SL; Assaf GS; Dalmora ME; Vaucher LC; Vaccari SF
    Rev Hosp Clin Fac Med Sao Paulo; 1991; 46(2):59-62. PubMed ID: 1843369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of N-deacetylation and N-desulfation of heparin on its anticoagulant activity and in vivo disposition.
    Bjornsson TD; Schneider DE; Hecht AR
    J Pharmacol Exp Ther; 1988 Jun; 245(3):804-8. PubMed ID: 3164387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of rat smooth muscle cell adhesion and proliferation by non-anticoagulant heparins.
    Kazi M; Lundmark K; Religa P; Gouda I; Larm O; Ray A; Swedenborg J; Hedin U
    J Cell Physiol; 2002 Dec; 193(3):365-72. PubMed ID: 12384988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biological monitoring of low molecular weight heparin. Value of a new chronometric tests, the Heptest].
    Delahousse B; Gruel Y; Moalic P; Foloppe P; Leroy J
    J Mal Vasc; 1987; 12 Suppl B():71-3. PubMed ID: 2834496
    [No Abstract]   [Full Text] [Related]  

  • 13. [Low molecular weight heparin fractions. Comparative preclinical study of various parameters].
    Fareed J
    J Mal Vasc; 1987; 12 Suppl B():59-63. PubMed ID: 2834492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the mechanism of heparin action by modification of its structure.
    Danishefsky I
    Fed Proc; 1977 Jan; 36(1):33-5. PubMed ID: 830555
    [No Abstract]   [Full Text] [Related]  

  • 15. [In vitro and in vivo neutralisation of a low molecular weight heparin fraction CY 216 by protamine].
    Doutremepuich C; Bonini F; Masse A; Bousquet F; Bayrou B; Toulemonde F
    Ann Pharm Fr; 1986; 44(1):65-72. PubMed ID: 3777780
    [No Abstract]   [Full Text] [Related]  

  • 16. [Low molecular weight heparins].
    Kher A; Bara L; Samama M
    Pathol Biol (Paris); 1986 Jan; 34(1):61-9. PubMed ID: 3517772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of crude heparin and commercial preparation of Polish production].
    Jarzebiński J; Tońska S; Remiszewska H
    Acta Pol Pharm; 1989; 46(2):179-82. PubMed ID: 2561044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo studies on the inhibition of coagulation by fractionated heparin and by a heparin analogue. I. Effects of heparin fractions.
    Schmitz-Huebner U; Balleisen L; Asbeck F; van de Loo J
    Thromb Haemost; 1981 Oct; 46(3):612-6. PubMed ID: 7031982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The minimal functional sequence of protamine.
    Liang JF; Yang VC; Vaynshteyn Y
    Biochem Biophys Res Commun; 2005 Oct; 336(2):653-9. PubMed ID: 16139792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparins: varying effects on cell proliferation in vitro and lack of correlation with anticoagulant activity.
    Lippman MM; Mathews MB
    Fed Proc; 1977 Jan; 36(1):55-9. PubMed ID: 830557
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.